Red blood cell surface adhesion molecules: Their possible roles in normal human physiology and disease

Red blood cell surface adhesion molecules: Their possible roles in normal human physiology and disease

Red Blood Cell Surface Adhesion Molecules: Their Possible Roles in Normal Human Physiology and Disease Human erythrocytes express a relatively large ...

1MB Sizes 100 Downloads 122 Views

Red Blood Cell Surface Adhesion Molecules: Their Possible Roles in Normal Human Physiology and Disease

Human erythrocytes express a relatively large number of known adhesion receptors, despite the fact that red blood cells (RBCs) are generally considered to be nonadhesive for endothelial cell surfaces. Some of these adhesion receptors are expressed by many other tissues, while others have more limited tissue distribution. Some adhesion receptors, including CD36 and VLA-4, are only expressed by immature erythroid cells, while others are present on mature erythrocytes. The structure and function of these proteins is reviewed here. LW, CD36, CD58, and CD147 have been shown in other tissues to mediate cell-cell interaction. Other receptors, such as CD44, VLA-4, and B-CAM/LU, can mediate adhesion to components of extracellular matrix. In addition, their roles in normal erythropoiesis, as well as in the pathophysiology of human disease, are summarized. The most convincing evidence for a pathophysiologic role for any of these receptors on erythrocytes comes from studies of cells from patients homozygous for hemoglobin S, as RBC adhesion is thought to contribute to vaso-occlusion. Thus, receptors such as B-CAM/LU may become targets for future therapy aimed at preventing or ameliorating this thrombotic process. Semin Hematol3 7:130-142. Copyright 0 2000 by W.B. Saunders Company.

II”

GENERAL, the major rolesof the erythrocytesuch as oxygen and carbon dioxide transporthave not been thought to require red blood cell (RBC) adhesion.Adhesion of blood cells has been hypothesized to be reserved for such fYmctions as occlusion of sitesof vascularinterruption by platelets or as a preliminary stagein the migration of leukocytes out of blood vesselsand into other tissues. Nevertheless,it hasnow becomeapparent that erythrocytes express on their surfacesmany molecules known to provide adhesionfunctions in other cells.In addition, at least one protein (band 3), a transport protein whose homologs in other tissuesare not generallythought to be involved in adhesion,hasnow been shown to play a role in adhesionunder certain circumstances.Furthermore, at least three human diseases are associated with adhesionof REKs, and in two, adhesionis likely to be integral to pathogenesis. Therefore, it is timely to review which adhesion

moleculesare expressedon the surfaceof erythrocytes, as well as to assess evidence for the role of these molecules both in normal physiology and in the pathophysiology of human disease.

From the Division ofHematology and ComprehensiveSickle Cell Center, Duke UniversityMedical Center,Durham, NC. Supported in part b Grant No. ROl HL58939 fiorn the National Heart, Lung and Blood Imtitute, NationalInstitutes of Health Address reprint requeststo Marilyn J T&n, MD, Box 2615, Duke Umiversi~Medical Center,Durbam, NC2771 0. Copyright 0 2000 b WB. Saunders Company

Molecules Whose tipression to Reticulocytes

0037-1963/00/3702-0004$10.00/O 130

Adhesion Molecules Expressed by Erythrocytes The adhesion proteins known to be expressedon immature and mature circulating erythrocytes are listed in Table 1. The functions of many of these moleculeshave been at least partially characterized through the study of nonerythroid and, in somecases, nonhematopoietic tissues.As illustrated in Fig 1, many of these moleculesare proteins with one or more immunoglobulin superfamily (IgSF) domains and thus belong to a classof ubiquitous adhesion molecules responsiblefor both cell-cell and cellextracellularmatrix interactions.

Is Limited

Two adhesion molecules, CD36 and VL,A-4, are limited to reticulocytes among RBCs. Except during stressreticulocytosis, these molecules are relatively weakly expressedby immature circulating RBCs and are lost ascellsprogressbeyond the reticulocyte stage. CD36, also known as glycoprotein IV when

Seminars in Hematology, Vo137, No 2 (April), 2000:~~ 130-142

131

RBC Suvjiie Adhesion Molecules

Table 1. Adhesion Molecules Erythrocytes Adhesion Molecule

CD36 VLA-4 CD44 CD47 CD58

CD99 CDwl08 CD147 ICAMB-CAM/LU CDw75 Band 3

Expressed

by Circulating

Blood Alternate

Name

Platelet glycoprotein 0~~8~ integrin Hyaluronan receptor Integrin-associated protein Lymphocyte-associated antigen-3 MIC2 gene product

IV

receptor

Anion exchanger

Naka (platelets) Indian

(Ina/lnb)

JMH Oka LW Lutheran

Neurothelin Laminin

Group Antigens (where known)

(AE-1)

Diego,

Wright

expressedby platelets,isa protein of 471 amino acids. It hasat leastone transmembranedomain composed of amino acid residues439 to 465; its 438%amino acid N-terminal region may be entirely extracellular or may contain a secondtransmembraneregion. Its short C-terminal domain (residues 466 to 471) residesin the cytoplasm. Glycoprotein IV is a major membraneglycoprotein of plateletsand is alsohighly expressedby mature monocytes and macrophages, microvascularendothelial cells,mammary endothelial B-CAM/l-U LFA3

1. Erythrocyte adhesion molecules belonging to the immunoglobulin superfamily (IgSF). Mature erythrocytes bear a number of surface proteins containing 1 or more IgSF domains. LFA-3 (lymphocyte function-associated antigen-3, CD58) is attached to the membrane by a glycosylphosphatidylinositol anchor, while LW, Oka (neurothelin), and BCAM/LU are type I membrane proteins with external amino termini and a single transmembrane domain. However CD47, also known as integrin-associated protein, is predicted to have 5 transmembrane domains. Not pictured is the VLA-4 (very late antigen-4) heterodimer, which is only expressed by immature RBCs (reticulocytes).

Figure

cells, and some macrophage-deriveddendritic cells. Glycoprotein IV hasbeenshown to be a receptor for thrombospondin and may alsobe capableof acting as a receptor for collagentypes I, IV and V46 CD36 also binds oxidized low-density lipoprotein, long-chain fatty acids, and anionic phospholipids.35,70 In addition to its important role in platelet adhesion and aggregation,CD36 may act in the recognition and phagocytosisof apoptotic cells,9oaswell asin plateletmonocyte and platelet-tumor cell interactions. Its activity is at leastpartially regulatedby phosphorylation, and the protein is physically associatedwith SK family kinasesin the platelet membrane.5,54 VIA-4, the other adhesion protein limited to reticulocytes, is a heterodimer comprising integrin chains CD49d (~4) and CD29a @J. VIA-4 expressedby lymphocytes and in other tissuesis known to be involved in both cell-cell and cell-extracellular matrix interactions. VIA-4 promotes leukocyteendothelial cell static adhesion through interaction with RAM-I, especiallyas expressedby activated endothelial cells,88~‘31 and this associationinduces a variety of events in the targeted endothelial cells. VIA-4 also binds the propolypeptide of von Willebrand factor.57Lie many other adhesionmolecules, VIA-4 can undergo activation, possibly through a pathway requiring phospholipaseC, Ca2+ mobilization, and/or the Kit receptor.x7,96~‘32 At least some evidence suggeststhat VIA-4 activation may be complex, as a variety of epitopes appear to mediate adhesionto different ligands.7xThe cytoplasmic domain of VIA-4 may be associatedwith cytoskeletal proteins. Adhesion or ligand binding through VIA-4 appearsto have various effectson different tissues;for example,VIA-4 hasbeenpostulatedto play a role in activation of memory B lymphocytes98and to prevent apoptosisof CD34+ stem cells.6,55J’23 Some of the rolesthought to be important for VIA-4 alsoappear to involve its interaction with another membrane protein, CD44. 25~100~121 The CD44 protein is expressedduring erythropoiesis, as well as by mature RBCS,“~ and will be discussedbelow.

Molecules

Expressed by Mature

Erythrocytes

Surprisingly, a number of adhesionproteins remain abundantly expressedin the membranesof mature erythrocytes. One of the first such proteins to be identified on RBCs was CD44, originally described on erythrocytes as In@)-related ~80. CD44 of erythrocytes is an 80-kd type I transmembranepro-

tein42,103 whose expression on erythrocytes is suppressed by the autosomal-dominant In (Lu) gene.l15,1I6 The CD44 protein is a receptor for hyaluronan, as well as for fibronectin.2J59,121 CD44 may serve to anchor epithelial cells to hyaluronan in the basement membrane and to maintain polar orientation. CD44 is involved in leukocyte attachment to and rolling on endothelial cells and in lymphocyte homing to peripheral lymphoid organs and migration to sites of inflarnmation.29,33 It also appears to be important in leukocyte aggregation, which may involve homologous association of CD44. The function of CD44 varies with cell activation: exposure of cells expressing recombinant CD44 to phorbol esters increased CD44 ability to bind hyaluronan, and the pattern of glycosylation of CD44 also regulates its ability to bind its ligands. In some cells, growth factors have been shown to change such glycosylation patterns.11,13,32,h5,73 CD44 activation may also involve G proteins. 2oSignaling throug h CD44 when it binds its ligands can induce cytokine release by leukocytes, as well as provoke T-cell activation. In addition, accumulating evidence strongly supports a role for CD44 in the metastatic potential of a wide variety of cancer cells.lo7 CD47, also called integrin-associated protein, is a transmembrane glycoprotein with five membranespanning domains and a single extracellular V-type IgSF domain.75 In the RBC membrane, CD47 appears to be associated with the Rh macromolecular complex; Rh,d cells express reduced amounts of CD47.75 CD47 forms a signaling complex with l31 and p3 integrins and functionally couples to heterotrimerit Gi proteins. 39CD47 has also been shown to be a receptor for thrombospondin in some tiss~es~~ and facilitates leukocyte spreading and chemotaxis,80~s1 as well as platelet aggregation.28 CD47 knockout mice exhibit a severe defect in leukocyte-mediated defenses against bacterial infection.74 CD%, also called lymphocyte function-associated antigen-3 (LFA-3), is a glycosylphosphatidylinositol (GE?)-anchored protein on erythrocytes, although its mRNA undergoes alternate splicing, giving rise to both GPI-anchored and transmembrane forms on other cells.94,122The extracellular domain of LFA-3 contains one V-type and one CZtype IgSF domain. LFA-3 is widely expressed by both hematopoietic and nonhematopoietic tissues. Among nonhematopoietic tissues expressing LFA-3 are endothelial cells, epithelial cells, and fibroblasts. LFA-3 effects cell-cell adhe-

sion through binding to its ligand, CD2.3,4,84 LFA-3 mediates a number of diierent cell-cell interactions, including interactions between killer and target cells, between antigen-presenting cells and T cells, and between thymocytes and thymic epithelial cells. Ligand binding to LFA-3 provides a costimulatory signal in the immune response. On lymphocytes, its activity is at least partially regulated by CD44.49 The CD99 glycoprotein, also’ called the MICZ gene product, is remarkable for containing five glyX-Y repeats such as those found in collagen and collagen-like proteins. lo CD99 is encoded by a gene in the pseudoautosomal region of the X chromosome, and this gene escapes X-inactivation.43 On thymocytes and T cells, CD99 is involved in rosette formation, as anti-CD99 antibodies block spontaneous T-cell rosettes.16 In RBCs, CD99 is only detectable at the surface of cells that express the X-linked gene encoding xg”; Xg(a-) RBCs have detectable CD99 in the cells, but not at the surface.41 Monoclonal antibodies to CD99 also induce surface exposure of phosphatidylserine in human lymphocytes.’ CDwlO8 is also a GPI-anchored protein and has been shown to carry the JMH blood group antigen. 18,77Although long postulated to serve an adhesion function, little in detail has been known about the function of CDwlO8, due to the fact that its cDNA sequence has only become available recently.130 However, studies in lymphocytes have shown that CDwIO8 is associated with protein tyrosine kinases in the membrane.’ CDwl08 is preferentially expressed on activated lymphocytes, as well as on REKs.~‘~ It is now known to have a single R-G-D (arg-gly-asp) sequence, a common motif for adhesion function. 130 CD147, also called neurothelin, is a transmembrane glycoprotein whose extracellular N-terminal domain contains two C2-type IgSF domains.63 Its 2 l-amino acid transmembrane domain is unusual in that it contains a leucine zipper and charged residues that are highly conserved among species, including rat, chicken, and humans; both of these characteristics offer potential sites of protein-protein interaction. CD147 is expressed by many types of hematopoietic cells, as well as by epithelium and some endothelium.‘06 However, one epitope of CD147 is not presented by RBCs or resting lymphocytes. In contrast, expression of this epitope is markedly increased in granulocytes from patients with rheumatoid arthritis.38 The assignment of an adhesive function to

RBC Su$ae Adhesion Moleada

CD147 comes from several types of observations. Soluble recombinant CD147 binds to various cell types, including endothelial cells and fibroblasts. In addition, some anti-CD 147 monoclonal antibodies inhibit aggregation of the breast cancer cell line MCF-7 and/or inhibit adhesionof MCF-7 cells to type IV collagen, laminin, and fibronectin.” However, more specific information regarding target ligandsfor CD 147 isnot available. LW which has also been called ICAM-4, is a glycoprotein bearing the LW blood group antigens and is homologous to intercellular adhesion molecules (ICAMs 1-3).8 Among hematopoietic cells, expressionof LW appearsrestricted to erythrocytes. LW is a type I transmembrane protein with two extracellularC2 IgSF domains.In RBCs, LW appears to be expressedas part of the macromolecular Rh protein complex, along with the Rh peptides,the Rh glycoprotein (I&50), CD47, and glycophorin B.26 LW antigensare relatively poorly expressedwhen the RhD polypeptide is absent, as in the RhD-negative blood group phenotype.72Recombinant LW protein has been shown capable of binding CD1 l/CD 18 leukocyte integrins.’ B-CAM/LU comprises a pair of spliceoforms encoded by the Lutheran blood group gene.24t82,85 B-CAM (basal cell adhesion molecule) was first describedasa protein expressedat the basalsurfaceof epithelial cells and was thus hypothesized to be an adhesionmolecule that might play a role in attachment of the basal surface of epithelial cells to the basement membrane.24The cDNA for B-CAM encodesa 58%amino acid type I transmembrane glycoprotein containing five IgSF domains: two Vtype and three C2-type domains.The cDNA encoding Lutheran, describedshortly thereafter,encodedan identical protein except for the cytoplasmic domain, which contained an additional 40 amino acids in which a proline-rich motif similar to other sequences known to bind SH3 domainswas found.82The two cDNAs were then shown to arise by alternative splicing of a single pre-mRNA.s5 B-CAM/LU has ratherwide tissuedistribution and isespeciallystrongly expressedby the basalcell layer of epithelium and by endothelial cells.In at leastsometissues,such asliver, expression of B-CAM/LU is also developmentally regulated.82B-CAM/LU hasnow beenshown to be a receptor for laminin. 120Although relatively inactive on normal RBCs, both its expressionand its activity are increasedon RBCs from patients with sickle cell

133

disease.120 B-CAM/LU expressionis also high on a number of malignant epithelial tumors, which also losethe polarity of B-CAM/LU expressionof normal tissues.24 Both spliceoformsbear identical Lutheran blood group antigens,as their extracellular domains are identical. B-CAM/LU is similar in structure to two other known human membraneproteins:CD 166 (ALCAM; activated leukocyte cell adhesion molecule)21and CD 146 (MUC 18, basigin).56,63,93 While neither of theseother proteins is expressedby RBCs, they are also both adhesionmoleculesand mediate cell-celland cell-extracellularmatrix interactions. CDw75 is a sialoglycan with a core epitope comprising NeuAc-(or2,6)gal-(p 1,4)GlcNAc; its expression is thus dependent on the function of an a2,6-sialyltransferase. 12,67CDw75 is weakly expressed by normal RBCs but is increasedin RBCs of the In&) Lu(a-b-) phenotype4’ and perhapsalso in certain diseases(Telen, unpublished observations). CDw75 is expressedby mature circulating surface immunoglobulin-positive B cells,aswell asby B cells of lymphoid secondaryfollicles. A small subpopulation of T cells also expressesCDw75. CDw75 mediatesB cell-B cell interactions through adhesion to its ligand, CD22.36,104 Erythrocyte band 3, alsocalledanion exchanger1 &El), ispart of a fam;ly of anion transport channels and is one of the major membrane proteins of RBCS~~J~*-~~~; about one million copiesof band 3 are present in the membrane of each RBC. Band 3 mediatesCl-/HC03- exchangeasan integral part of respiration. Band 3 is also important to membrane stability and providesa link from the lipid membrane to the cytoskeletonvia its interaction with ankyrin. l l l Band 3 spansthe membrane multiple times, as do most membrane transport proteins, and it bearsa singlelarge oligosaccharideon its fourth extracellular domain.‘12 Severallines of evidence suggestthat at leastone extracellular protein domain plays a role in adhesionaswell.

Possible Roles of Adhesion Molecules in Normal Erythrocyte Biology The adhesion molecules expressedby erythrocytes and discussedabove suggestthat RBCs have at least the potential capability of adhering to a number of ligands,including thrombospondin, fibronectin, laminin, hyaluronan, endothelial cells, and leukocytes. Since adhesionmoleculesare expressedby both early

and mature erythrocytes, it is natural to ask whether these molecules serve an important physiologic fimction during erythropoiesis or, perhaps, during cell senescence. Moreover, if adhesion molecules are only important during erythropoiesis, why are they not lost completely from the membrane of the mature erythrocyte, as is, for example, the transferrin receptor? At this time, we have many more questions than answers. What we have learned thus far is the nature of the targets of these receptors, as outlined above, as well as some of the adhesion characteristics RBCs exhibit during specific stages of development.

Adhesion

Molecules

During

Erythropoiesis

Both pluripotent stem cells and erythroid progenitor cells are believed to “home” to the bone marrow microenvironment, a fact that makes stem cell transplantation possible. Fetal liver and umbilical cord stem cells appear to display different adhesion molecules and diierent adhesion characteristics compared with adult bone marrow progenitor cells.89 However, relatively little is known about the molecules that mediate stem cell adhesion and homing,99 or about the factors or processes that trigger and effect release of more mature cells from the bone marrow into the circulation. Early erythroid progenitors adhere to fibronectin, an extracellular matrix component relatively abundant in bone marrow. Adhesion of erythroid progenitors to fibronectin appears to require the ~$1 integrin (VLA-4), as well as CD44.i21 CD44 is also thought to play a role in adhesion of clonogenic progenitor cells to bone marrow stromal cells; such adhesion can be modulated by antibodies to CD44, concomitantly affecting clonal proliferation. Conversely, downregulation of expression of CD49d (the 014protein of VIA-4) may be important in stem cell release from the bone marrow, such as during granulocyte colony-stimulating factor administration prior to peripheral blood stem cell harvesting by apheresis. lo5 However, other evidence suggests that adhesion and release may be affected by activation or inactivation of adhesion molecules, rather than regulation of expression.45 Additional evidence that other adhesion molecules may be critical for erythroid development is scant. One study implicated GPI-linked molecules in the process of progenitor cell adhesion to bone marrow stroma, but these molecules remain unidentified. In addition, a study of a family in which two siblings had an unusual form of congenital dyserythropoietic

anemia showed that the two affected siblings, but not the unaffected siblings or the parents, had a deficiency of Owl08 from their RBCS.~*~‘~J’~ Thus far, no further relationship has been shown between the CDw 108 deficiency and the congenital anemia. Study of a special class of reticulocytes has offered further insight into the role of adhesion molecules during erythropoiesis. Stress reticulocytes are made during periods of increased marrow activity, as with hyperproductive erythropoiesis due to blood loss or accelerated BBCs destruction; congenital anemias such as thalassemia and sickle cell anemia are also associated with stress reticulocytosis. Stress reticulocytes can be distinguished from normal reticulocytes: they demonstrate increased “2 and decreased “I” antigen expression, increased expression of CL,& integrin, and increased CD36.“i They may also contain higher concentrations of fetal hemoglobin. what is not known is whether the characteristics of these cells are simply the result of premature release from the bone marrow, possibly due to having undergone one less cell division than normal, or whether there is a different level of expression of certain genes due to specific signaling pathways active during heightened hematopoietic activity. A further question is whether any of these differences are functionally useful during increased RBC turnover. While increased expression of adhesion molecules should hamper exit of young RBCs from the bone marrow, it appears that expression of these molecules is increased just when release of more and perhaps younger RBCs is required! However, several lines of evidence suggest that stress reticulocytes may be shorter-lived than normal reticulocytes, due either to the quality of the cells or to host physiology.

Adhesion Molecules Cell Clearance

and Physiologic

Circulating erythroid cells are removed when they become senescent; that is, RBCs do not leave the circulation randomly. Bather, there is a mechanism for the detection of RBCs that are no longer functionally viable, and these cells are specifically cleared from the circulation while normal RBCs are not. Senescent, old, RBCs are characterized by their content of increased amounts of denatured globin,l19 as well as decreased protein kinase activity”“,67 The surface of such cells bears increased amounts of adsorbed QZ2’ Senescent BBC band 3 has reduced associations with the cytoskeleton and undergoes clustering.86 Alter-

135

RBC Su$aceAdhesion Molecules

ation of the large band kssociated polysaccharides also occurs during REX2 aging.14,15Aged RBCs bear an epitope that has been termed the “senescent cell antigen,” which is thought to be a neoepitope of band 3. However, senescent Rl3Cs adhere to vascular endothelial cells no more avidly than do normal RBCs, suggesting that clearance of senescent cells may not be dependent on adhesion to splenic and other reticuloendothelial system endothelial cells. On the other hand, their clearance may depend on macrophages, either through immunoglobulin bound to the RBC surface or by other adhesion mechanisms.22

Possible Roles of Adhesion Molecules in Human Disease Altered RBC adhesion has been found to be characteristic of three human diseases: malaria, diabetes mellitus, and sickle cell disease. Thus far, the mechanism for increased adhesion in each condition appears distinctive; adhesion of RBCs may contribute in a unique way to the overall pathophysiology of each disease.

RBC Adhesion

in Malaria

Malaria is one of the most prevalent infectious diseases in the world. Four species of Phnzodium parasites are known to cause human disease: P falcz$amn, P viva, P ovaik and P mahrzhe. Au of these parasites are transmitted through mosquito bites to humans as sporozoites and then travel to the liver, where they mature in hepatocytes, ultimately giving rise to numerous merozoites, which then invade circulating REV2 Transmission of malaria from one human to another through the mosquito vector, as well as much of the morbidity and mortality of malarial disease, relate in large measure to the cytoadherence of infected RBCs to endothelium. The development and survival of intraerythrocyte gametocytes is thought to depend critically on the ability of infected cells to sequester in the microvasculature of various organs, including spleen and bone marrow. In addition, manifestations such as cerebral malaria are thought to be due to adhesion and sequestration of infected RBCs in the microvasculature. Although several REV2 membrane proteins have long been thought to act as receptors for various Pkzvnodium species, the evidence that erythrocyte membrane proteins act as mediators of adhesion by infected RBCs to endothelial cells is more recent.

Synthetic peptides based on motifs of extracellular loops 3 and 7 of band 3 have been shown to inhibit this adhesion.30 Furthermore, production of murine monoclonal antibodies to infected human RBCs has resulted in antibodies that reacted with exofacial band 3 peptides31 This picture is complicated, however, by another finding: Phmodium parasites produce a protein termed RESA, part of which is homologous to the sequence of human band 3 implicated in adhesion. It appears uncertain, therefore, whether the adhesion of parasitized RBCs is primarily dependent on alterations of band 3 at the surface of parasitized cells or results from presentation of the parasite protein at the RBC surface.97

RE3C Adhesion

in Diabetes Mellitus

Although diabetes mellitus is primarily a disorder of absolute or relative insulin deficiency leading to abnormal glucose utilization, much of the morbidity and mortality of the disease comes from the associated accelerated atherosclerosis. Individuals with diabetes, who comprise about 14 million United States residents and 120 million people worldwide, have twoto fourfold more coronary and cerebral vascular disease than the population overall. This increased incidence of vascular disease is believed to result from the widespread metabolic disturbances observed in diabetes, including abnormal metabolism of carbohydrates, fats, and proteins. During the early development of atherosclerotic lesions, monocytes and macrophages containing large amounts of cholesterol accumulate in the subendothelial space. Eventually, the overlying endothelial monolayer is sufhciently disturbed that both subendothelial extracellular matrix proteins and macrophages are exposed to circulating blood cells. Platelets are among the adherent cells, and the ensuing cellular responses of platelets, endothelial cells, and monocytes stimulate the proliferation of smooth muscle cells. As this cycle proceeds, cellular debris rich in lipids, as well as additional extracellular matrix proteins, accumulate in the subendothelial space, and an atherosclerotic plaque forms. For many years, it has been observed that erythrocytes from patients with diabetes demonstrate abnormal adhesion to endothelial cells. In I98 1, Wautier et al showed that RBCs from patients with diabetes adhered to cultured umbilical vein endothelial cells

136

Marilyn]. Tel&

significantly more than did normal erythrocytes.125 Furthermore, the degree of increased adhesion observed for individual patients was related to the degree of vascular complications. 125These studies led to the hypothesis that a diabetes-related abnormality of BBCs contributes to diabetic vascular disease. Adhesion of RBCs has been shown to lead to prostacyclin release’26 and has been associated with morphologic changes in cultured endothelial cells. 127 One process known to lead to biochemical abnormalities of RBC membranes is nonenzymatic glycation. This reaction affects protein amine groups: in the presence of high glucose concentrations, aldimines are formed and then undergo rearrangements to form ketoamines. Eventually, glucose-derived crosslinks can be formed, leading to production of advanced glycation end products (AGES). Thus, although glycosylated hemoglobin is traditionally measured as an indication of long-term glucose control, the presence of these AGES is similarly the result of the control or lack of control of glucose levels. 124 AGES appear to mediate adhesion to endothelial cells, and endothelial cells have a specific receptor for these moieties. This receptor (RAGE) was cloned in 1992 and was shown to be an IgSF molecule containing one V-type and two C2-type domains, as well as a single transmembrane domain.79 Occupation of this receptor with appropriate ligands produced a positive feedback loop involving increased expression of RAGE and cellular activation.92 Infusion of soluble RAGE in mice was able to block the accelerated atherosclerosis otherwise observed92J28; thus, RBC adhesion to endothelial cells via the AGE-RAGE ligand-receptor pair is likely to have a pathogenic role in the vascular disease associated with diabetes. Work is now proceeding to determine what pharmacologic interventions in addition to tight glucose control can disrupt the AGE-RAGE pathway of endothelial damage.58J34 It also remains to be determined whether RBCs from diabetic individuals have additional abnormalities that affect erythrocyte adhesion or cell-cell interactions. Some investigators have found subtle cell surface abnormalities in RBCs from patients with diabetes. Decreased membrane fluidity and increased lipid peroxidation have been associated with the condition,76 as has a decreased RBC life spana One study demonstrated that RBCs from diabetic individuals express less CD59 on their surfaces,129 while

studies of the expression of acetylcholinesterase, another GPI-linked protein, have produced contradictory results. Whether the expression and function of transmembrane proteins, and especially adhesion molecules, is affected by diabetes remains to be determined. In addition, RBCs in diabetics are relatively deficient in reduced glutarhione, a fact that may predispose to oxidative damage to membrane proteins and lipids. ’ l8 Oxidative stress can in turn increase the formation of glycation end products.58

RBC Adhesion

in Sickle Cell Disease

The stereotypical painful crises and multiorgan darnage characteristic of sickle cell disease result from vaso-occlusion. Sickle cell vaso-occlusion follows both directly and indirectly from the unique properties of the mutant gene product hemoglobin S. When deoxygenated hemoglobin S undergoes polymerization, accumulation of elongated hemoglobin crystals produces cell deformation and reduces elasticity, thus preventing RBCs from passing through capillaries and the small vascular spaces of the spleen. However, increased polymerization of hemoglobin S above a baseline state is likely not the cause of vaso-occlusive crises.34 The tendency of sickle RBCs to form abnormal cell-cell and cell-extracellular matrix adhesions, together with abnormal activation of the coagulation system, are felt to be key factors in pathogenesis (Fig &23,37,51,53,66

Endothelial damage is also characteristic of sickle cell disease. Evidence of such damage includes the presence of increased numbers of circulating endothelial cells, their activated phenotype, and the fact that contact of sickle RBCs with endothelial cells in vitro causes activation and alteration of the phenotype of endothelial cells.17,68,95J01J02When the endothelial lining of blood vessels is severely damaged, the matrix of subendothelial proteins may become exposed to flowing blood, thus making ECM components as well as endothelial cells themselves likely targets for sickle RBC attachment. The adhesive interactions observed in various experimental systems appear to involve BBC adhesion to both endothelial cells as well as to ECM components. 34,50Both static assays and tests under flow conditions document sickle cell adhesion to laminin, thrombospondin,62,‘20 and fibronectinG4 as well as to endothelial cells in culture.53 However,

137

RBC Su f&e Adhesion iVfolecu~s

Altered Membrane Proteins and Surface Properties of Sickle RBC jx_(,_ (__*j=---- -“-~-.l.>m * l-;__lql_lxtll .+ ___._- ^“-b, Activation of =.---v-?-m --=w Increased RBC Adhesion ~ *‘+ Coagulation / 1’ Adhesion to Endotheliu&nd Subendothelium Matrix H Increased Gelation ; .” 4 --;>>*<~~’ *i ‘I ‘,? I*

St Mechanic!! Obstruction~=+~~~$&,ed Tr&Sit Time B #’ ‘9 \? 3 *I’ gb\*, ks ;u a. --*,* P ‘%+-“yv& -x ‘**-------~-~ Endothelial Damage/Activation

Figure 2. Pathways involving RBC adhesion in vasoocclusion. RBCs from patients with sickle cell disease exhibit a number of surface abnormalities, including membrane protein alterations and derangement of normal lipid sidedness, with exposure of phosphatidylserine. These alterations have been hypothesized to contribute to activation of the coagulation system, as well as to RBC adhesion to endothelial cells and extracellular matrixcomponents. Adhesion of RBCs appears to contribute to a cycle of endothelial damage, leading to more cellular adhesion. Delayed transit time of RBCs containing hemoglobin S may then lead to increased gelation and further derangement of the red cell surface.

normally bear a relatively large number of known or putative adhesion molecules, including CD44 (a hyaluronan receptor that can alsoact asa ligand for fibronectin, laminin, and collagen),2,47,59 IAP (a thrombospondin receptor),40,75LW (ICAM-4, an ICAM- homolog),8,9and B-CAM/LU (a laminin receptor).24,82,85J20J33 Sickle RBCs may be more adhesivedue to increasedexpressionof theseadhesion moleculesor due to activation of usually quiescent proteins. Examples abound of cell surface receptors that require activation before they becomecapableof binding their ligands. It has been well demonstrated that CD44 in resting lymphocytes or in transfected cellsexhibits little adhesionto hyaluronan, while the samecellsexposedto various stimuli, such asphorbol estersthat activate protein kinaseC, show markedly increasedhyaluronan binding.l l7 The cytoplasmic portion of CD44 is known to be required for this effect to 0ccut-.7~,~~7 In addition, binding of some antibody ligands (but not others) has a similar effect on CD44, in both nucleated cells and erythrocytes.73.1

sickle cell adhesionto fibronectin and thrombospondin is much weaker than is adhesionto laminin.52~71 The causesof increasedstickinessof sickle RBCs may be multiple. Several investigators have shown that hemoglobin SS-containing, but not hemoglobin AA- or AS-containing reticulocytes, bear the integrin a&t, a moleculecapableof binding fibronectirP and VCAM-1, aswell asglycoprotein n/: which in some circumstancesis a receptorfor collagenand thrombospondin. As has already been discussed,all RBCs

17

The interaction of sicklered cellswith laminin via the B-CAM/LU receptor is the best characterized adhesionphenomenonknown to involve sickleRBCs. B-CAM/LU mediatesa high-affinity interaction of sickleRBCs with laminin, ableto resistshearstresses presentin both small and medium caliber vessels,as shown when recombinant B-CAM/LU is expressed in transfected cells (Fig 3).120In addition, the fifth IgSF domain of B-CAM/LU has been identified as responsible for the interaction with laminin,

1 0.9

Figure 3. Adhesion to immobilized laminin of murine erythroleukemia (MEL) cells expressing either vector alone or a construct encoding recombinant B-CAM. MEL cells transfected with vector alone adhered only minimally to laminin in a variable-height flow chamber.120 However, cells expressing recombinant B-CAM adhered to laminin with a critical shear stress (level at which 50% of cells remain attached) of >lO dyne/cm*.

-Vector

0

2

4

6 Shear

8 Stress.

10 dyne/cmA2

12

14

16

h!adel

but the epitope involved has not been precisely defined.‘33 The process producing alteration of BCAM/LU so that it binds laminin on sickle RBCs could be due to one or more of several factors. Sickle RBCs express an increased B-CAMILU copy number,133 but the scale of this overexpression is not in accord with the degree of increased adhesion sickle RBCs exhibit. Other factors could include association of B-CAM/LU molecules with each other or with other altered membrane proteins, or more direct alteration of the cytoplasmic domain of B-CAM/LU by phosphorylation or by association with other proteins. Much research remains to be accomplished to determine how the adhesion molecules of sickle RBCs are rendered active and how this activity can be interrupted to reverse or prevent vaso-occlusion.

Summary The progressive characterization of the erythrocyte membrane at a molecular level, along with the identification of the functions of the various proteins, has led to the recognition that both immature and mature RBCs express a large number of adhesion molecules. We have yet to discover which adhesive interactions are critical for normal erythroid differentiation and if these adhesive interactions regulate release of RBCs from the bone marrow. We do not yet know whether disruption of any of these adhesive interactions produce abnormal or deficient erythroid differentiation. Nor do we understand how, in disorders such as sickle cell disease, what regulates the activity or inactivity of RBC adhesion molecules. Nevertheless, as many of the molecules implicated in adhesion have now been well characterized at a molecular level, the answers to these questions should be well within our reach.

References 1. Angelisova P Cinek T, Josek J, et al: Coprecipitation of protein kinases by the adhesion structure section mAb, in Schlossman SE Bournsell L, Gii W et al (eds): Leucocyte Typing V Oxford, England, Oxford University Press, 1995, pp 1482-1483 2. A&o A, Stamenkovic I, Melnick M, et al: CD44 is the principal ceil surface receptor for hyaluronate. Cell 61: 13031313,199o 3. Arulanandam AR, Kister A, McGregor MJ, et al: Interaction between human CD2 and CD58 involves the major

beta sheet surface of each of their domains. J Exp Med 180:1861-1871,1994 4. Arulanandam AR, Withka JM, Wyss (LFA-3) binding site is a localized surface area on the AGFCC’C” face adhesion domain. Proc Natl Acad

respective

adhesion

DE et al: The CD58 and highly charged of the human CD2 Sci USA 90:11613-

11617,1993 5. Asch AS, Liu I, Briccetti FM, et al: Analysis of CD36 binding domains: &and specificity controlled by dephosphorylation of an ectodomain. Science 262: 1436-1440, 1993 6. Asosingh K, Renmans W Van der Gucht K, et al: Circulating CD34+ cells in cord blood and mobilized blood have a different profile of adhesion molecules than bone marrow CD34+ cells. Eur J Haematol 60:153-160, 1998 JI: et al: Monodonal 7 Aussel C, Bernard G, Breittmayer antibodies directed against the E2 protein (MIC2 gene product) induce exposure of phosphatidylserine at the thymocyte cell surface. Biochemistry 32:10096-10101, 1993 P Callebaut I, et al: The LW blood group 8. BaiIly P Hermand glycoprotein is homologous to interceII&r adhesion molecules. ProcNatl AcadSci USA91:5306-5310,1994 P et al: The red cell LW blood 9. Bailly P, Tontti E, Hermand group protein is an intercellular adhesion molecule which binds to CD 1 l/CD 18 leukocyte integrins. Eut J Immunol 25:3316-3320,1995 10. Banting GS, Pym B, Darling SM, et al: The MIC2 gene product: epitope mapping and structural prediction analysis define an integral membrane protein. Mol Immunol26: 18 l188,1989 11. Bartolazzi A, No& A, Aruffo A, et al: Glycosylation CD44 is implicated in CD44-mediated cell adhesion hyaluronan. J Cell Biol132:1199-1208,1996

of to

12. Bast BJ, Zhou LJ, Freeman GJ, et al: The HB-6, CDw75, and CD76 differentiation antigens are unique cell-surface carbohydrate determinants generated by the beta-galactoside alpha 2,6-sialyltransferase. J Cell Biol 116:423435, 1992 B, Greenfield B, et al: Regulation of 13. Bennett KL, Modrell CD44 binding to hyaluronan by glycosylation of variably spliced exons. J Cell Biol131:1623-1633, 1995 14. Beppu M, Ando K, Kikugawa K: Poly-iV-acetyllactosaminyl sac&ride chains of band 3 as determinants for anti-band 3 autoantibody binding to senescent and oxidized erythrocytes. Cell Mol Biol (Noisy-le-grand) 42:10071024,1996 15. Beppu nants located tein. J

M, Mizukami A, Ando K, et al: Antigenic determiof senescent antigen of human erythtocytes are in sialylated carbohydrate chains of Band 3 glycoproBiol Chem 267:14691-14696,1992

16. Bernard G, Zoccola D, Deckert M, et al: The E2 molecule (CD99) specifically triggers homotypic aggregation of CD4+ CD8+ thymocytes. J Immunol 154:26-32, 1995 17. Blei F, Fancher T, Guarini L: Elevated levels of circulating

RBC &face Adhesion MoIecuik

18.

19.

20.

21.

molecules of potential endothelial origin in sickle cell disease. Blood 84:409a, 1994 (suppl 1, abstr) Bobolii KA, Moulds JJ, Telen MJ: Isolation of the JMH antigen on a novel phosphatidylinositol-linked human membrane protein. Blood 79:1574-l 581, 1992 Bobolis KA, Telen MJ: Markedly weakened expression of JMH in a kindred with congenital hemolytic anemia. Transfusion 3 1:46S, 199 1 (suppl, abstr) Bourguignon LY Iida N, Welsh CF, et al: Involvement of CD44 and its variant isoforms in membrane-cytoskeleton interaction, cell adhesion and tumor metastasis. J Neuroonco1 26:201-208, 1995 Bowen M, Pate1 DD, Li X, et al: Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand. J Exp Med 181:2213-

2220,1995 22. Bratosin D, Mazurier J, Tissier JP et al: Molecular mechanisms of erythrophagocytosis. Characterization of the senescent erythrocytes that are phagocytized by macrophages. C RAcad Sci III 320:811-818, 1997 23. Brittain HA, F&man JR, Wick TM: Sickle erythrocyte adherence to large vessel and microvascular endothelium under physiologic flow is qualitatively different. J Lab Clin Med 120:538-545, 1992 24. Campbell IG, Foulkes WD, Senger G, et al: Molecular cloning of the B-CAM cell surface glycoprotein of epithelial cancers: A novel member of the immunoglobulin superfamily Cancer Res 54:5761-5765, 1994 25. Cao L, Yoshino T Kawasaki N, et al: Binding of human leukocytes to fibronectin is augmented by an anti-CD44 mAb (TL-1) and blocked by another anti-CD44 mAb (Hermes-3) but not by anti-VLA-4NLA-5 mAbs. Immunobiology 196:504-512, 1996 26. Cartron JP: Defining the Rh blood group antigens. Biochemistry and molecular genetics. Blood Rev 8:199-212,1994 27. Christian JA, Rebar AH, Boon GD, et al: Senescence of canine biotinylated erythrocytes: Increased autologous immunoglobulin binding occurs on eryrhrocytes aged in vivo for 104 to 110 days. Blood 82:3469-473, 1993 28. Chung J, Gao AG, Frazier WA: Thrombspondin acts via integrin-associated protein to activate the platelet integrin a.~&~. J Biol Chem 272:14740-14746,1997 29. Clark RA, Alon R, Springer TA: CD44 and hyaluronandependent rolling interactions of lymphocytes on tons&r stroma. J Cell Biol134:1075-1087, 1996 30. Crandall I, Collins WE, Gysin J, et al: Synthetic peptides based on motifs present in human band 3 protein inhibit cytoadherencelsequestration of the malaria parasite P.&nodium falciparum. Proc Nat1 Acad Sci USA 90:4703-4707, 1993 31. Crandall I, Sherman IWz Cytoadherence-related neoantigens on Phsmodium falciparum (human malaria)-infected human erythrocytes result from the exposure of normally cryptic regions of the band 3 protein. Parasitology 108:257267,1994 32. Dasgupta A, Takahashi K, Cutler M, et al: O-linked glycosylation modifies CD44 adhesion to hyaluronate in

139

colon carcinoma cells. Biochem Biophys Res Commun 222110-l 17,1996 33. DeGrendele HC, Estess P Siegelman MH: Requirement

34.

35.

36.

37.

for CD44 in activatedT cell extravasation into an intkunmatory site. Science 278:672-675, 1997 Embury SH, Hebbel Rp, Steinberg MH, et al: Pathogenesis ofvasoocclusion, in Embury SH, Hebbel RI: Mohandas M, et al (eds): Sickle Ceil Disease: Basic Principles and Clinical Practice. New York, NY, Raven, 1994, pp 31 l-326 Endemann G, Stanton LW, Madden KS, et al: CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 268:11811-11816, 1993 Engel P NojimaY, Rothstein D, et al: The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils, and monocytes. J Immunoll50:4719-4732,1993 Failer DV: Vascular modulation, in Embury SH, Hebbel RP Mohandas N, et al (eds): Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY, Raven,

1994, pp 235-246 38. Felzmann T Gadd S, Majdic 0, et al: Analysis of functionassociated receptor molecules on peripheral blood and synovial fluid granulocytes from patients with rheumatoid and reactive arthritis. J Clin Immunol 11:205-212, 1991 39. Frazier WA, Gao AG, Dimitty J, et al: The thrombospondin receptor integrin-associated protein (CD47) functionally couples to heterotrimeric Gi-proteins. J Biol Chem 274:8554-8560, 1999 40. Gao AG, Lindberg FP Finn MB, et al: Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J Biol Chem 271:21-24,1996 41. Gelin C, Aubrit F, Phalipon A, et al: The E2 antigen, a 32 kd glycoprotein involved in T-cell adhesion processes, is the MIC2 gene product. Embo J 8:3253-3259,1989 42. Goldstein LA, Zhou DE Picker LJ, et al: A human lymphoqe homing receptor, the Hermes antigen, is related to cartilage link proteoglycan core and link proteins. Cell 56:1063-1072,1989 43. Goodfellow E Pym B, Mohandas T et al: The cell surface antigen locus, MIC2X, escapes X-inactivation. Am J Hum Genet 36:777-782, 1984 44. Gordon MY, Lewis JL, Ma&y SB, et al: Stromal cells negatively regulate primitive haemopoietic progenitor cell activation via a phosphatidylinositol-anchored cell adhesion/ signalhng mechanism. Br J Haematol96:647-653, 1997 45. Gotoh A, Ritchie A, Ttiira H, et al: Thrombopoietin and erythropoietin activate inside-out signaling of integrin and enhance adhesion to immobilized fibronectin in human growth-factor-dependent hematopoietic cells. Ann Hemato1 75:207-213, 1997 46. Greenwalt DE, Lipsky RH, Ockenhouse CF, et al: Membrane glycoprotein CD36: A review of its roles in adherence, signal transduction, and transfusion medicine. Blood 80:1105-1115,1992 47. Gunthert U: CD44: A multitude of isoforms with diverse functions. Curr Top Microbial Immunol 184:47-63, 1993 48. Guy K, Green C: The influence of the In(Lu) gene on

expression of CDw75 ImmunoIogy75:713-716,

antigens on human 1992

X red blood cells.

49. Hale LI: Singer KH, Haynes BF: CD44 antibody against In&]-related ~80, lymphocyte-homing receptor molede inhibits the binding of human erythrocytes to T cells. J Immunol143:3944-3948,1989 50. Hebbel R: Perspectives series: CeII adhesion in vascular biology. Adhesive interactions of sickle erythrocytes with endothelium. J Clin Invest 992561-2564, 1997

64.

65.

66.

N: Sickle cell adherence, in Embury 51. Hebbel Iu: Mohandas SH, Hebbel RI? Mohandas N, et al (eds): Sickle Ceil Disease: Basic Principles and Clinical Practice. New York, NY, Raven, 1994, pp 217-230

67.

CA, Du MC, Montgomery RR, et al: Increased 52. Wery adhesion of eryrhrocytes to components of the extracellular matrix: Isolation and characterization of a red blood cell lipid that binds thrombospondin and laminin. Blood 87:4879-4886,1996

68.

53. Hoover R, Rubin R, Wise G, et al: Adhesion of normal and sidle erythrocytes to endorhelial monolayer cuItures. Blood 54:872-876,1979 Bolen JB, Barnwell Jw; et al: Membrane 54. Huang MM, glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets. Proc NatI Acad Sci USA 88:7844-7848, 1991 RW McCarthy JB, Wayner EA, et al: Monoclonal 55. H&y antibody crosslinking of the alpha 4 or beta 1 integrin inhibits committed donogenic hematopoietic progenitor proliferation. Exp Hematol25:321-328, 1997 K, Taguchi 0, et al: Roles of basigin, 56. Igakura T, Kadomatsu a member of the immunoglobulin superfamily in behavior as to an irritating odor, lymphocyte response, and bloodbrain barrier. Biochem Biophys Res Commun 224:33-36, 1996 57. Isobe T, Hisaoka T, Shimizu A, et al: Propolypepnde of von Wiiebrand factor is a novel Iigand for very late antigen-4 integrin. J Biol Chem 272:8447-8453,1997 58. Jain SK, Palmer M: The effect of oxygen radicals metabolites and vitamin E on glycosylarion of proteins. Free Radic Biol Med 22:593-596, 1997 M: Lymphocyte CD44 binds the 59. JaIkanen S, J&anen COOH-terminal heparin-binding domain of fibronectin. J Cell Biol 116:817-825, 1992 60. Jindal HK, Ai Z, Gascard P et al: Specific loss of protein kinase activities in senescent eryrhrocytes. Blood 88:14791487,1996 61. Joneckis CC, AckIey RL, Orringer EI: et al: Integrin alpha 4 beta 1 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle ceII anemia. Blood 82:35483555,1993 62. Joneckis CC, Shock DD, Cunningham ML, et al: Glycoprotein IV-independent adhesion of sickle red blood cells to immobilized thrombospondin under flow conditions. Blood 87:4862-4870,1996 63. Kasinrerk W Fiebiger E, Stefanova I, et al: Human leukocyte activation antigen Mb, a member of the Ig superfamily,

69. 70.

71

72.

73.

74.

is the species homologue of rat 0X-47, mouse basigin, and chicken HT7 molecule. J ImmunoI149:847-854,1992 Kasschau M, Barabino G, Bridges K, et al: Adhesion of sickle neutrophils and erythrocytes to fibronectin. Blood 87:2771-2780,1996 Katoh S, Zheng Z, Oritani K, et al: Glycosylation of CD44 negatively regulates its recognition of hyahtronan. J Exp Med 182:419,1995 KauI D, Fabry M, Nagel R: Erythrocytic and vascular factors influencing the microcirculatory behavior of blood in sickle ceII anemia. Ann NYAcad Sci 565:316-326, 1989 Keppler OT, Moldenhauer G, Oppenlander M, et al: Human Golgi beta-galactoside alpha-2,6-sialyltransferase generates a group of sialylated B lymphocyte differentiation antigens. Eur J Immunol22:2777-278 1, 1992 I&g PP Kay N, Jensen WN: Endothelial cell and vascular damage in the sickle ceII disorder. Blood cells 8:175-l 84, 1982 Kopito RR: Molecular biology of the anion exchanger gene family. Int Rev Cyrol 123:177-199,199O Krieger M, Herz J: Structures and functions of muItiIigand lipoprotein receptors: Macrophage scavenger receptors and LDL receptor-related protein (IRP). Annu Rev Biochem 63:601-637, 1994 Lee SP Cunningham ML, Hines PC, et al: Sickle cell adhesion to laminin: potential role for the alpha5 chain. Blood 92:2951-2958, 1998 Levine I: Celano MJ: Agglutinating specificity for LW factor in guinea pig and rabbit anti-I% serums. Science 156:1744-1746, 1967 Liao HX, Levesque MC, Patton K, et ak Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonaI and polyclonal antibodies. J Immunol 151:6490-6499, 1993 Lindberg FI: BuIIard DC, Caver TE, et al: Decreased resistance to bacterial infection and granulo~e defects in

LAP-deficient mice. Science 274:795-798, 1996 75. Lindberg FI: Lublin DM, Telen MJ, et al: Rh-related anrigen CD47 is the signal-transducer integrin-associated protein. J Biol Chem 269:1567-1570, 1994 L, FaIoia E, Rabini RA, et aI: Diabetes meIIitus 76. Mazzanti induces red blood ceII plasma membrane alterations possibly affecting the aging process. Clin Biochem 25:41-46, 1992 R, Rao N, Angelisova P et al: Evidence that 77. Mudad CDwl08 membrane protein bears the JMH blood group antigen. Transfusion 35:566-570, 1995 78. Munoz M, Serrador J, Nieto M, et al: A novel region of the alpha4 integrin subunit with a modulatory role in VLA-C mediated cell adhesion to fibronectin. Biochem J 327:727733,1997 79. Neeper M, Schmidt AM, Brett J, et al: Cloning and expression of a ceII surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267:1499815004,1992 80. Parkos CA: Cell adhesion and migration. I. NeutrophiI

141

RBC Su$ae Adhesion Molecuh

adhesive interactions with intestinal epithelium. Am J Physiol273:G763-G768, 1997 81. Parkas CA: Molecular events in neutrophi transepithelial migration. Bioessays 19:865-873, 1997 G, Holmes CH, et al: The Lutheran 82. Parsons SF, Mallinson blood group glycoprotein, another member of the immunoglobulin superfamily, is widely expressed in human tissues and is developmentally regulated in human liver. Proc Natl Acad Sci USA 92:5496-5500,1995 83. Ghigo D, Bosia A, Pagani A, et al: Changes in erythrocyte deformability following changes in oxido-reductive metabolism in diabetes mellitus. Ric Clin Lab 13:375-381, 1983 84.

85

86.

87.

88.

89.

90.

91.

92.

93.

(suppl3) Plunkett ML, Sanders ME, Selvaraj P, et al: Rosetting of activated human T lymphocytes with autologous erythrocytes. Definition of the receptor and l&and molecules as CD2 and lymphocyte function-associated antigen 3 (LFA3). J Exp Med 165:664-676, 1987 Rahuel C, Le Van Kim C, Mattei MG, et al: A unique gene encodes spliceoforms of the basal-cell adhesion molecule cell surface glycoprotein of epithelial cancer and of the Lutheran blood group glycoprotein. Blood 8831865-1872, 1996 Rettig MP, Low PS, Gimm JA, et al: Evaluation of biochemical changes during in vivo erythrocyte senescence in the dog. Blood 93:376-384, 1999 Ricard I, Payet MD, Dupuis G: Clustering the adhesion molecules VLA-4 (CD49cLCD29) in Jurkat T cells or VCAM-1 (CD106) in endothelial (ECV304) cells activates the phosphoinositide pathway and triggers Ca2+ mobilization. Eur J Immunol27:1530-1538,1997 Robinson LA, Tu L, Steeber DA, et al: The role of adhesion molecules in human leukocyte attachment to porcine vascular endothelium: Implications for xenotransplantation. J Immunol161:6931-69381998 Roy V, V&&illie CM: Expression and function of cell adhesion molecules on fetal liver, cord blood and bone marrow hematopoietic progenitors: Implications for anatomical localization and developmental stage specific regulation of hematopoiesis. Exp Hematol27:302-3 12, 1999 Savill J, Fadok V, Henson P et al: Phagocyte recognition of cells undergoing apoptosis. Immunol Today 14:131-136, 1993 Schiavone EM, Tortora V, Armetta I, et al: CD147 Workshop: Expression, modulation, and involvement in homotypic aggregation and adhesion to matrix of molecules recognized by monoclonal antibodies to CD147 on breast cancer cell lines, in Kishimoto T, Kikutani H, von dern Borne AEG Kr, et al (eds): Leukocyte Typing VI. New York, NY, Garland, 1997, pp 764-766 Schmidt AM, Yan SD, Wautier JL, et al: Activation of receptor for advanced glycation end products: A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 84:489-497, 1999 Schuster VL, Lu R, Kanai N, et al: Cloning of the rabbit homologue of mouse ‘b&gin’ and rat ‘0X-47’: Kidney cell type-specific expression, and regulation in collecting duct cells. Biochim Biophys Acta 1311:13-19, 1996

94. Seed B: An LFA-3 cDNA encodes membrane protein homologous to ture 329:840-842, 1987 JJ, E&man 95. Sherrill AW, Wiiams contact with sickle erythrocytes elongation of arterial endothelium. (suppl I, abstr)

a phospholipid-linked its receptor CD2. NaJR, et al: Short-term inhibits shear-induced Blood 84:407a, 1994

96. Shibayama H, Anzai N, Ritchie A, et al: Interleukin-3 Flt3-ligand induce adhesion of Baf3/Flt3 precursor lymphoid cells to fibronectin via activation of VIA4 VLA-5. Cell Immunol 187:27-33, 1998

and Band

97. Siddique AB, Ahlborg N, Wahlin Flyg B, et al: Antibodies to sequences in a non-repeat region of P/&mod&z falcipdrum antigen Pfl55/RESA inhibit either cytoadherence or parasite growth in vitro. Parasitology 117:209-216, 1998 P et al: A role for the VIA-4 98. Silvy A, Altevogt I: Mondiere integrin in the activation of human memory B cells. Eur J Immunol27:2757-2764,1997 99. Simmons I’J, Levesque ecules in haemopoiesis.

JP Zannettino AC: Adhesion molBaillieres Clin Haematol IO:485

505,1997 100. Smadja-Joffe E Legras S, Girard N, et al: CD44 and hyaluronan binding by human myeloid cells. Leuk Lymphoma 2 1:407-420, 1996 101. Solovey A, Lin Y Browne I: et al: Circulating activated endothelial cells in sickle cell anemia. N Engl J Med 337:1584-1590,1997 102. Sowemimo-Coker SO, Meiselman HJ, Francis RB Jr: Increased circulating endothelial cells in sickle cell crisis. Am J Hematol31:263-265, 1989 103. Stamenkovic I, Amiot M, Pesando JM, et al: A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link family Cell 56:1057-1062,1989 104. Stamenkovic I, Sgroi D, Aruffo A, et al: The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and alpha 2-6 sialyltransferase, CD75,onBcells. Cell66:1133-1144, 1991 105. Steen R, Tjonnfjord GE, Gunnes Groseth LA, et al: Efflux of CD34+ cells from bone marrow to peripheral blood is selective in steady-state hematopoiesis and during G-CSF administration. J Hematother 6:563-573, 1997 106. Stockinger H, Ebel T Hansmann C, et al: CD147 (neurothelin/basigin) workshop panel report, in Kishimoto T, Kikutani H, von dern Borne AEG Kr, et al (eds): Leukocyte Typing VI. New York, NY, Garland, 1997, pp 760-763 107. Streit M, Schmidt R, Hilgenfeld RU, et al: Adhesion receptors in malignant transformation and dissemination of gastrointestinal tumors. J Mol Med 74:253-268,1996 108. Tanner MJ: The major integral proteins cell. Baillieres Clin Haematol6:333-356,

of the human 1993

red

109. Tanner MJ: Molecular and cellular biology of the erythrocyte anion exchanger &El). Semin Hematol 30:34-57, 1993 110. Tanner MJ: The structure and function of band 3 @El): Recent developments. Mol Membr Biol 14:155-165, 1997 111. Tanner MJ, Bruce L, Groves JD, et al: The defective red cell

112.

113.

114.

115.

116.

117.

118.

anion transporter (band 3) in hereditary South East Asian ovalocytosis and the role of glycophorin A in the expression of band 3 anion transport activity in &nopzlr oocytes. Biochem SocTians 20:542-546,1992 Tanner MJ, Martin PC, High S: The complete amino acid sequence of the human erythrocyte membrane aniontransport protein deduced from the cDNA sequence. Biochem J 256:703-712,1988 Helen MJ: Erythrocyte blood group antigens: Polymorphisms of functionaIIy important molecules. Semin Hemato1 33:302-314, 1996 Telen MJ: CDwl08, in Protein Reviews on the Web National Center for Biotechnology Information. http:// www.ncbi.nlm.gov/PROW/guide/1037914632_g.htm, 1998 Telen MJ, Eisenbarth GS, Haynes BF: Human erythrocyte antigens. Regulation of expression of a novel erythrocyte surface antigen by the inhibitor Lutheran In(Lu) gene. J Clin Invest 71:1878-1886, 1983 Telen MJ, Palker TJ, Haynes BF: Human erythrocyte antigens: II. The In(Lu) gene regulates expression of an antigen on an 80kilodakon protein of human erythrocytes. Blood 64:599-606, 1984 Helen MJ, Udani M, Washington MK, et al: A blood group-related polymorphism of CD44 abolishes a hyaluronan-binding consensus sequence without preventing hyaluronan binding. J Biol Chem 271:7147-7153, 1996 Thornalley PJ, McLeIlan AC, Lo Tw, et ah Negative association between eryrhrocyte reduced glutathione concentration

and diabetic

complications.

Clin Sci (Colch)

91:575-

582,1996 119. Turrini F, Mannu F, Arese I: et ah Characterization of the autologous antibodies that opsonize erythrocytes with clustered integral membrane proteins. Blood 8 I:3 146-3 152, 1993 120. Udani M, Zen Q, Cottman M, et al: Basal cell adhesion molecule/Lutheran protein: The receptor cell adhesion to laminin. J Clii Invest

critical for siclde 101:2550-2258,

1998 121. Ver&Uie C, Benis A, Iida J, et ah Adhesion of committed human hematopoietic progenitors to synthetic peptides from the C-terminal heparin-binding domain of fibronectin: Cooperation between the integrin alpha 4 beta 1 and the CD44 adhesion receptor. Blood 84: 1802- 18 11,1994 122. WalIner BP Frey AZ, Tizard R, et al: Primary structure of lymphocyte function-associated antigen 3 (LFA-3). The Iigand of the T lymphocyte CD2 glycoprotein. J Exp Med

166:923-932,1987

123. Wang

Mw; Consoli U, Lane CM, et al: Rescue from apoptosis in early (CD34-selected) versus late (non-CD34selected) human hematopoietic cells by very late antigen 4and vascular cell adhesion molecule &CAM) l-dependent adhesion to bone marrow stromal cells. Cell Growth Differ 9:105-112, 1998

124. Wautier

JL, LeBlanc H, Wautier MP et ah Erythrocyte adhesion to cultured endothelium and gIycaemic control in type 1 (insulin-dependent) diabetic patients. Diabetologia 29:151-155, 1986

125. Wautier

JL, Paton RC, Wautier MP, et al: Increased adhesion of erythrocytes to endothelial cells in diabetes mellitus and its relation to vascular complications. N EngI J Med 305:237-242, 1981

126. Wautier

JL, Pintigny D, MacIouf J, et al: Release of prostacydin after erythrocyte adhesion to cultured vascular endothelium. J Lab Clin Med 107:210-2151986

127. Wautier

JL, Wautier ME GuiIIam-Megnin C, et al: Endothelial cells and adhesion of red cells in diabetes and sickle cell anemia. Quantitative and qualitative aspects. Nouv Rev Fr Hematol26:379-385, 1984

128. Wautier

JL, Zoukourian C, Chappey 0, et ah Receptormediated endothelial ce!l dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J Clin Invest

97~23%243,1996 129.

Whittaker DS, Telen MJ: Expression of phosphatidylinositollinked proteins and blood group antigens in diabetic patients. Transfusion 34:63S, 1994 (suppl, abstr)

130. Yamada A, Kubo K, Takeshita T, et al: Molecular a gIycosylphosphatidylinositol-anchored J Immunol162:4094-4100,1999

131. Yamada KM: Adhesive recognition 266:12809-12812,

cloning of molecule CDwlO8.

sequences. J Biol Chem

1991

132. Yuan Q, Ansten KF, Friend

DS, et al: Human peripheral blood eosinophils express a functional c-kit receptor for stem cell factor that stimulates very late antigen 4 (VLA-4)mediated cell adhesion to fibronectin and vascular cell adhesion molecule I (VCAM-1). J Exp Med 186:313-323, 1997

133. Zen Q, Cottman

M, Tiuskey G, et ah Critical basal cell adhesion molecule/Lutheran-mediated to laminin. J Biol Chem 274:728-734,1999

134. Zoukourian

factors in adhesion

C, Wautier MP, Chappey 0, et al: Endorhelial cell dysfunction secondary to the adhesion of diabetic erythrocytes. Modulation by iloprost. Int Angiol 15:195-

200,1996